[Surgical patients with severe sepsis: first results of the PROWESS study. Demographic data].
Montravers
P
P
Département d'anesthésie-réanimation, CHU Jean-Verdier, avenue du 14-Juillet, 93143 Bondy, France.
Blaise
M
M
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D011486:Protein C / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins / Q000627:therapeutic use*; D012307:Risk Factors; D018805:Sepsis / Q000150:complications / Q000188:drug therapy*; D012720:Severity of Illness Index; D013514:Surgical Procedures, Operative
D000890:Anti-Infective Agents; D011486:Protein C; D011994:Recombinant Proteins; C421124:drotrecogin alfa activated